|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.05 DKK | +0.02% |
|
-0.34% | -24.04% |
| Mar. 14 | How are different indices influenced? | |
| Mar. 13 | Form Health Joins Lilly Employer Connect Platform | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Diabetes and Obesity Care | 122B | 156B | 215B | 272B | 289B | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | 4.9B | 5.7B | 8.2B | 7.1B | 13.06B | |||||
Operating Income | 49.54B | 67.4B | 99.62B | 128B | 126B | |||||
Rare Disease | 19.2B | 20.54B | 17.16B | 18.64B | 19.61B | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | 1.13B | 1.66B | 1.22B | 1.44B | 1.6B | |||||
Operating Income | 9.11B | 7.41B | 2.95B | 620M | 1.21B | |||||
Total Assets | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States of America (USA) | 63.01B | 84.66B | 128B | 167B | 173B | |||||
Total Assets | - | - | - | 57.14B | 77.39B | |||||
CAPEX | - | - | - | - | - | |||||
Total Assets | - | - | - | 177B | 195B | |||||
Europe and Canada | - | - | - | - | 66.09B | |||||
Emerging Markets | - | - | - | - | 30.44B | |||||
APAC | - | - | - | - | 20.71B | |||||
Region China | 16.02B | 16.21B | 16.69B | 18.5B | 18.66B | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EMEA | 37.71B | 44.24B | 50.87B | 60.4B | - | |||||
North America (Excl. US) | 4.25B | 6.45B | 9.1B | 10.77B | - | |||||
Total Assets | - | - | - | - | - | |||||
Africa, Asia, Middle East and Oceania (AAMEO) | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Latin America | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Pacific | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Japan & Korea | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Europe | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Rest of the World | 19.81B | 25.4B | 28.08B | 33.33B | - | |||||
International Operations | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - |
- Stock Market
- Equities
- NOVO B Stock
- Financials Novo Nordisk A/S
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















